University of Arizona clinical trial pipeline

8 trials changed in the last 30 days: 0 stopped, 4 with notable changes, 4 with minor changes only.

1. Notable

   Extended Follow-Up Study of the HPV Vaccine Delayed Booster Trial

   Primary endpoint(s) modified

   Also in this update: Results posted: Oct 9, 2026; Study completion pushed from Dec 2025 to Dec 2026

   University of Arizona·Not specified· NCT04688476· Registry history of NCT04688476 on ClinicalTrials.gov (opens the registry)

   Oct 9, 2026

2. Notable

   18F-Fluciclovine PET/CT to Identify Brain Metastasis

   Phase changed: Phase 2 → Early Phase 1

   University of Arizona·Early Phase 1· NCT06055790· Registry history of NCT06055790 on ClinicalTrials.gov (opens the registry)

   Sep 21, 2026

3. Notable

   CLEAR · Circadian Light Exposure Adjustment for Restfulness

   Recruitment opened

   Also in this update: Primary completion pushed from Dec 1, 2029 to Dec 31, 2029; Study completion moved earlier from Jul 31, 2030 to Mar 31, 2030

   University of Arizona·Not applicable· NCT07391852· Registry history of NCT07391852 on ClinicalTrials.gov (opens the registry)

   Oct 14, 2026

4. Notable

   VEDA Study (DHEA vs Estradiol)

   Recruitment opened

   University of Arizona·Not applicable· NCT07574216· Registry history of NCT07574216 on ClinicalTrials.gov (opens the registry)

   Sep 21, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.